Carcinoma in Situ of Bladder
📧 Sign up to get email alerts when something new happens for Carcinoma in Situ of Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study [NA]
An open-label, single-arm Phase 2 trial is evaluating radiotherapy for BCG-unresponsive non-muscle-invasive bladder cancer with carcinoma in…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer [Phase 2]
This document reports a Phase 2 clinical trial evaluating radiotherapy for BCG-unresponsive non-muscle-invasive bladder cancer in situ (CIS)…
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. [Phase 3]
Phase 3 clinical trial investigating mitomycin C intravesical chemotherapy with Synergo radiofrequency-induced hyperthermia for Bacillus Cal…